K Forßmann

856 total citations
18 papers, 627 citations indexed

About

K Forßmann is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, K Forßmann has authored 18 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in K Forßmann's work include Cystic Fibrosis Research Advances (4 papers), Child Nutrition and Feeding Issues (3 papers) and Heart Failure Treatment and Management (3 papers). K Forßmann is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Child Nutrition and Feeding Issues (3 papers) and Heart Failure Treatment and Management (3 papers). K Forßmann collaborates with scholars based in Germany, United States and United Kingdom. K Forßmann's co-authors include D. Hock, Peter Schulz‐Knappe, Florian‐Alexander Herbst, W. G. Forssmann, Rüdiger Pipkorn, Michael Buchfelder, Bernhard Saller, Christian J. Strasburger, K. Mann and Michael Droste and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Pediatrics and American Heart Journal.

In The Last Decade

K Forßmann

18 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Forßmann Germany 10 231 184 183 139 111 18 627
Jiandong Zhang China 14 156 0.7× 192 1.0× 82 0.4× 50 0.4× 132 1.2× 22 651
Shuyu Li China 12 131 0.6× 80 0.4× 166 0.9× 142 1.0× 63 0.6× 36 476
Ewald Kolesnik Austria 13 203 0.9× 176 1.0× 100 0.5× 47 0.3× 136 1.2× 54 463
Märit Wallander Sweden 11 120 0.5× 242 1.3× 115 0.6× 33 0.2× 182 1.6× 15 614
S-L Wang China 8 111 0.5× 179 1.0× 95 0.5× 39 0.3× 96 0.9× 26 513
Cosimo Sacra Italy 13 350 1.5× 146 0.8× 134 0.7× 49 0.4× 126 1.1× 29 604
Anna Di Martino Italy 9 189 0.8× 302 1.6× 160 0.9× 41 0.3× 241 2.2× 13 636
Giuseppe Palmiero Italy 14 358 1.5× 103 0.6× 126 0.7× 128 0.9× 172 1.5× 54 802
Monia Vezzoli Italy 9 170 0.7× 174 0.9× 61 0.3× 32 0.2× 124 1.1× 14 521
Poorna R. Karuparthi United States 12 217 0.9× 205 1.1× 182 1.0× 86 0.6× 122 1.1× 30 647

Countries citing papers authored by K Forßmann

Since Specialization
Citations

This map shows the geographic impact of K Forßmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Forßmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Forßmann more than expected).

Fields of papers citing papers by K Forßmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Forßmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Forßmann. The network helps show where K Forßmann may publish in the future.

Co-authorship network of co-authors of K Forßmann

This figure shows the co-authorship network connecting the top 25 collaborators of K Forßmann. A scholar is included among the top collaborators of K Forßmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Forßmann. K Forßmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Forssmann, Wolf‐Georg, Hanns-Christian Tillmann, D. Hock, et al.. (2016). Pharmacokinetic and Pharmacodynamic Characteristics of Subcutaneously Applied PTH-1-37. Kidney & Blood Pressure Research. 41(5). 507–518. 6 indexed citations
3.
Heubi, James E., David J. Schaeffer, Richard C. Ahrens, et al.. (2016). Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial. The Journal of Pediatrics. 176. 156–161.e1. 15 indexed citations
4.
Heubi, J E, David J. Schaeffer, Richard C. Ahrens, et al.. (2016). WS17.6 A randomized, controlled clinical trial of a liquid microbial lipase (NM-BL) in patients with exocrine pancreatic insufficiency due to cystic fibrosis. Journal of Cystic Fibrosis. 15. S29–S29. 2 indexed citations
5.
Heubi, James E., David J. Schaeffer, Richard C. Ahrens, et al.. (2016). A randomized, controlled clinical trial of a novel microbial lipase (NM-BL) in patients with exocrine pancreatic insufficiency due to cystic fibrosis. Pancreatology. 16(3). S108–S108. 2 indexed citations
6.
Forßmann, K, et al.. (2011). Administration of CREON® Pancrelipase Pellets via Gastrostomy Tube is Feasible with No Loss of Gastric Resistance or Lipase Activity. Clinical Drug Investigation. 31(7). e1–e7. 13 indexed citations
7.
Graff, Gavin R., John McNamara, James A. Royall, Steven Caras, & K Forßmann. (2010). Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis. Clinical Drug Investigation. 30(6). 351–364. 22 indexed citations
8.
Rasmussen, Åse Krogh, Beverly M. K. Biller, Michael Buchfelder, et al.. (2007). Clinical Implications of Residual Growth Hormone (GH) Response to Provocative Testing in Adults with Severe GH Deficiency. The Journal of Clinical Endocrinology & Metabolism. 92(7). 2604–2609. 17 indexed citations
9.
Buchfelder, Michael, Michael Droste, K Forßmann, et al.. (2007). Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study. European Journal of Endocrinology. 156(1). 75–82. 156 indexed citations
10.
Mitrović, Veselin, Hartmut Lüss, K Forßmann, et al.. (2005). Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: A double-blind, placebo-controlled, ascending-dose trial. American Heart Journal. 150(6). 1239.e1–1239.e8. 77 indexed citations
11.
Walker, S., et al.. (2003). Wirkmechanismen der vasokonstriktiven Therapie der Ösophagusvarizenblutung. Zeitschrift für Gastroenterologie. 41(10). 1001–1016. 7 indexed citations
12.
Flüge, Thomas, G Kunkel, Barbara Schneider, et al.. (1999). Bronchodilation using combined urodilatin - albuterol administration in asthma: a randomized, double-blind, placebo-controlled trial.. PubMed. 4(10). 411–5. 7 indexed citations
13.
Rumstadt, B., K Forßmann, Mirko Singer, & M. Trede. (1998). The Whipple partial duodenopancreatectomy for the treatment of chronic pancreatitis.. PubMed. 44(18). 1554–9. 25 indexed citations
14.
Forßmann, K, et al.. (1997). [Postoperative follow-up in patients with partial Whipple duodenopancreatectomy for chronic pancreatitis].. PubMed. 35(12). 1071–80. 18 indexed citations
15.
Forßmann, K, et al.. (1994). [Acute cholecystitis--conservative therapy].. PubMed. 83(32). 877–9. 2 indexed citations
16.
Singer, Manfred V. & K Forßmann. (1994). [Non-surgical therapy of pancreatitis complications (pseudocyst, abscesses, stenoses)].. PubMed. 83(32). 865–9. 2 indexed citations
17.
Schulz‐Knappe, Peter, K Forßmann, Florian‐Alexander Herbst, et al.. (1988). Isolation and structural analysis of “Urodilatin”, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Journal of Molecular Medicine. 66(17). 752–759. 204 indexed citations
18.
Forßmann, K, D. Hock, Florian‐Alexander Herbst, et al.. (1986). Isolation and structural analysis of the circulating human cardiodilatin (alpha ANP). Journal of Molecular Medicine. 64(24). 1276–1280. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiandong Zhang Breakdown of academic impact, for papers by Shuyu Li Breakdown of academic impact, for papers by Ewald Kolesnik Breakdown of academic impact, for papers by Märit Wallander Breakdown of academic impact, for papers by S-L Wang Breakdown of academic impact, for papers by Cosimo Sacra Breakdown of academic impact, for papers by Anna Di Martino Breakdown of academic impact, for papers by Giuseppe Palmiero Breakdown of academic impact, for papers by Monia Vezzoli Breakdown of academic impact, for papers by Poorna R. Karuparthi
Rankless by CCL
2026